AVOLLA Trademark

Trademark Overview

On Monday, May 17, 2021, a trademark application was filed for AVOLLA with the United States Patent and Trademark Office. The USPTO has given the AVOLLA trademark a serial number of 90715558. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, August 14, 2024. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The AVOLLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations
avolla

General Information

Serial Number90715558
Word MarkAVOLLA
Filing DateMonday, May 17, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, August 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Thursday, May 20, 2021NEW APPLICATION ENTERED
Saturday, August 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 12, 2021ASSIGNED TO EXAMINER
Friday, November 12, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, November 12, 2021EXAMINERS AMENDMENT E-MAILED
Friday, November 12, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 12, 2021EXAMINER'S AMENDMENT ENTERED
Friday, November 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 13, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, January 26, 2022ASSIGNED TO PETITION STAFF
Monday, February 7, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 26, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 26, 2022SOU EXTENSION 1 FILED
Tuesday, July 26, 2022SOU EXTENSION 1 GRANTED
Thursday, July 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 2, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, February 6, 2023SOU EXTENSION 2 FILED
Monday, February 6, 2023SOU EXTENSION 2 GRANTED
Wednesday, February 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 2, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 2, 2023SOU EXTENSION 3 FILED
Wednesday, August 2, 2023SOU EXTENSION 3 GRANTED
Friday, August 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 15, 2024SOU EXTENSION 4 FILED
Monday, March 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, March 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, March 19, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, March 19, 2024PETITION TO REVIVE-GRANTED
Tuesday, March 19, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, March 19, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, March 19, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, April 30, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 1, 2024SOU EXTENSION 4 GRANTED
Thursday, May 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU EXTENSION 5 FILED
Wednesday, August 14, 2024SOU EXTENSION 5 GRANTED

Related Keywords

avolla preparations pharmaceutical namely hormone therapy enhancement replacement contraceptive injectable contraceptives